Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDCO-2010 in Elective CABG Surgery
NCT01535222Phase 2Completed
- Sponsor
- The Medicines Company
- Start
- Nov 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of MDCO-2010 in perioperative hemorrhage (6 arms), sponsored by The Medicines Company. Primary endpoints: Incidence of Adverse Events at 7 days and Incidence of Serious Adverse Events at 7 days. Started Nov 2010; status: completed.
02
Drugs
MDCO-2010
03
Conditions
perioperative hemorrhage
Beyond the preview
Go deeper on NCT01535222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01535222.